DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Pengo V, Denas G, Zoppellaro G. et al.
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.
Blood 2018;
132 (13) 1365-1371
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.